Characteristics of the Epizootiology, Epidemiology, Diagnostics and Prevention of Crimean-Congo Hemorrhagic Fever

Crimean-Congo hemorrhagic fever (CCHF) is a particularly dangerous zoonotic arboviral infection caused by the RNA-containing CCHF virus (CCHFV) of the genus Orthonairovirus in the family Nairoviridae. The disease is characterized by a wide geographic range, covering more than 50 countries in Africa, Asia, and Europe, including regions of Ukraine. The natural circulation of the pathogen is sustained by complex interspecies interactions, in which ixodid ticks of the genus Hyalomma serve as the primary vectors and long-term reservoirs, capable of transphasic and transovarial transmission of the virus. Additional amplifiers of the virus include domestic and wild mammals (cattle, sheep, goats, rodents, and hares), as well as ostriches, in which the infection is typically asymptomatic, while migratory birds contribute to the expansion of the range by transporting infected ticks. Routes of human infection include both vector-borne transmission via tick bites and contact transmission—through exposure to the blood, bodily fluids, or tissues of infected animals during their care or slaughter. In addition, there is a high risk of human-to-human transmission, particularly nosocomial transmission through direct contact with hemorrhagic secretions from patients in the acute phase of the disease. Additional routes of transmission include the alimentary route (through consumption of raw meat or unpasteurized milk) and the sexual route. The pathogenesis and clinical course of CCHF in humans are phasic in nature. Following the incubation period, a prehemorrhagic phase develops, characterized by severe systemic intoxication, which subsequently progresses to the hemorrhagic phase, accompanied by a petechial rash, ecchymoses, multiple internal and external hemorrhages, thrombocytopenia, and a risk of developing disseminated intravascular coagulation and multiple organ failure. The average case-fatality rate is 11.7%. Diagnosis of the disease is based on the use of molecular genetic methods (RT-PCR) during the early days of viremia, as well as serological tests (ELISA) to detect antigens and specific IgM and IgG antibodies. All procedures involving the pathogen require a high level of biosafety (BSL-3/BSL-4). The therapeutic strategy involves intensive pathogenetic and supportive therapy combined with early administration of antiviral drugs, particularly ribavirin. This article provides a detailed description of existing vaccine candidates. Given the lack of commercially available vaccines, specific preventive measures play a key role in preventing outbreaks: acaricidal treatment of animals, use of personal protective equipment, adherence to food hygiene, and strict implementation of infection control measures in healthcare facilities.

Authors

Institutions

Publication Details

Journal
One Health Journal
Published
2026-11-19
DOI
https://doi.org/10.31073/onehealthjournal2026-v-01
Primary Topic
Viral Infections and Vectors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Characteristics of the Epizootiology, Epidemiology, Diagnostics and Prevention of Crimean-Congo Hemorrhagic Fever

М. С. Карпуленко, G. Kyivska, G. B. Aliekseieva, В. І. Задорожна et al.
One Health Journal
Viral Infections and Vectors
article

Characteristics of the Epizootiology, Epidemiology, Diagnostics and Prevention of Crimean-Congo Hemorrhagic Fever

М. С. Карпуленко, G. Kyivska, G. B. Aliekseieva, В. І. Задорожна, Oleksandr Pishchanskyi, Alla Podavalenko, Leonid Kornienko, N.P. Vynnyk, O. V. Matviienko, O. Lysiuk, V. V. Kulykova, N. V. Mazur
article en

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a particularly dangerous zoonotic arboviral infection caused by the RNA-containing CCHF virus (CCHFV) of the genus Orthonairovirus in the family Nairoviridae. The disease is characterized by a wide geographic range, covering more than 50 countries in Africa, Asia, and Europe, including regions of Ukraine. The natural circulation of the pathogen is sustained by complex interspecies interactions, in which ixodid ticks of the genus Hyalomma serve as the primary vectors and long-term reservoirs, capable of transphasic and transovarial transmission of the virus. Additional amplifiers of the virus include domestic and wild mammals (cattle, sheep, goats, rodents, and hares), as well as ostriches, in which the infection is typically asymptomatic, while migratory birds contribute to the expansion of the range by transporting infected ticks. Routes of human infection include both vector-borne transmission via tick bites and contact transmission—through exposure to the blood, bodily fluids, or tissues of infected animals during their care or slaughter. In addition, there is a high risk of human-to-human transmission, particularly nosocomial transmission through direct contact with hemorrhagic secretions from patients in the acute phase of the disease. Additional routes of transmission include the alimentary route (through consumption of raw meat or unpasteurized milk) and the sexual route. The pathogenesis and clinical course of CCHF in humans are phasic in nature. Following the incubation period, a prehemorrhagic phase develops, characterized by severe systemic intoxication, which subsequently progresses to the hemorrhagic phase, accompanied by a petechial rash, ecchymoses, multiple internal and external hemorrhages, thrombocytopenia, and a risk of developing disseminated intravascular coagulation and multiple organ failure. The average case-fatality rate is 11.7%. Diagnosis of the disease is based on the use of molecular genetic methods (RT-PCR) during the early days of viremia, as well as serological tests (ELISA) to detect antigens and specific IgM and IgG antibodies. All procedures involving the pathogen require a high level of biosafety (BSL-3/BSL-4). The therapeutic strategy involves intensive pathogenetic and supportive therapy combined with early administration of antiviral drugs, particularly ribavirin. This article provides a detailed description of existing vaccine candidates. Given the lack of commercially available vaccines, specific preventive measures play a key role in preventing outbreaks: acaricidal treatment of animals, use of personal protective equipment, adherence to food hygiene, and strict implementation of infection control measures in healthcare facilities.

One Health JournalVol. 4(V)
L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine (UA), State Scientific and Research Institute of Laboratory Diagnostics and Veterinary and Sanitary Expertise (UA), Kharkiv National Medical University (UA)
Good health and well-being
Viral Infections and Vectors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon